Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma
- 1 April 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 343 (8905) , 1059-1063
- https://doi.org/10.1016/s0140-6736(94)90180-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of high-dose intravenous immunoglobulin therapy on blood rheologyThe Lancet, 1992
- Current Patterns of Bacterial Infection in MyelomatosisScandinavian Journal of Infectious Diseases, 1984
- Biphasic Pattern of Bacterial Infection in Multiple MyelomaAnnals of Internal Medicine, 1982
- Influence of treatment and response status on infection risk in multiple myelomaThe American Journal of Medicine, 1981
- Prognostic features in the third MRC myelomatosis trial.British Journal of Cancer, 1980
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Infections Complicating Multiple Myeloma and Chronic Lymphocytic LeukemiaArchives of internal medicine (1960), 1973
- PART I. ANALYSIS OF PRESENTING FEATURES OF PROGNOSTIC IMPORTANCEBritish Journal of Haematology, 1973
- Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemiaThe American Journal of Medicine, 1963